Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 7/20 | 0.84 |
| ▸ | KMT2A | Q03164 | 7/20 | 0.84 |
| ▸ | USP2 | O75604 | 4/20 | 0.84 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.84 |
| ▸ | HAT1 | O14929 | 4/20 | 0.84 |
| ▸ | RBBP7 | Q16576 | 4/20 | 0.84 |
| ▸ | HTT | P42858 | 4/20 | 0.84 |
| ▸ | RECQL | P46063 | 3/20 | 0.84 |
| ▸ | CASP7 | P55210 | 3/20 | 0.84 |
| ▸ | MAPT | P10636 | 3/20 | 0.84 |
| ▸ | CASP1 | P29466 | 2/20 | 0.84 |
| ▸ | BRCA1 | P38398 | 2/20 | 0.84 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.84 |
| ▸ | TST | Q16762 | 2/20 | 0.84 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.84 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.84 |
| ▸ | LMNA | P02545 | 1/20 | 0.84 |
| ▸ | HBB | P68871 | 1/20 | 0.84 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.84 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.84 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Riboflavin SCHEMBL232228 | 1.00 | MEN1 (0.84) | MEN1KMT2AUSP2KDM4EHAT1 | |
| Riboflavin SCHEMBL27497064 | 0.99 | MEN1 (0.82) | MEN1KMT2AUSP2KDM4EHAT1 | |
| Riboflavin SCHEMBL5991517 | 0.95 | MEN1 (0.89) | MEN1KMT2AUSP2KDM4EHAT1 | |
| Riboflavin SCHEMBL5991520 | 0.95 | MEN1 (0.89) | MEN1KMT2AUSP2KDM4EHAT1 | |
| Riboflavin SCHEMBL6662783 | 0.95 | MEN1 (0.75) | MEN1KMT2AUSP2KDM4EHAT1 | |
| Riboflavin SCHEMBL27781309 | 0.95 | MEN1 (0.81) | MEN1KMT2AUSP2KDM4EHAT1 | |
| Riboflavin SCHEMBL27764351 | 0.95 | MEN1 (0.81) | MEN1KMT2AUSP2KDM4EHAT1 | |
| Riboflavin SCHEMBL2800233 | 0.94 | MEN1 (0.89) | MEN1KMT2AUSP2KDM4EHAT1 | |
| Riboflavin SCHEMBL2800236 | 0.94 | MEN1 (0.89) | MEN1KMT2AUSP2KDM4EHAT1 | |
| Riboflavin SCHEMBL27604024 | 0.93 | MEN1 (0.78) | MEN1KMT2AUSP2KDM4EHAT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 643 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260144875-A1 | COMPOSITIONS AND METHODS FOR CROSSLINKING STRUCTURAL PROTEINS | ADS THERAPEUTICS LLC (US) | 2026-05-28 | — | — | US | claimed |
| CN-122056386-A | Moisture absorption resistant slow release microcapsule powder and preparation method and application thereof | 大连医诺生物股份有限公司 | 2026-05-19 | — | — | CN | claimed |
| CN-122030612-A | Shear-resistant slow-release microcapsule powder and preparation method and application thereof | 大连医诺生物股份有限公司 | 2026-05-15 | — | — | CN | claimed |
| EP-4637775-A1 | COMPOSITIONS AND METHODS FOR CROSSLINKING STRUCTURAL PROTEINS | ADS Therapeutics LLC (US) | 2025-10-29 | — | — | EP | claimed |
| WO-2025131038-A1 | COMPOSITIONS AND METHODS FOR DELIVERY OF PHARMACEUTICAL ACTIVES | ADS THERAPEUTICS LLC (US) | 2025-06-26 | — | — | WO | claimed |
| US-20250188117-A1 | C-Terminal Peptide Modification | TECHNISCHE UNIVERSITEIT DELFT (NL) | 2025-06-12 | — | — | US | claimed |
| US-12312605-B2 | Riboflavin derivative-containing medium | AJINOMOTO CO., INC. (JP) | 2025-05-27 | — | — | US | claimed |
| CN-120004760-A | Ultrasonic activated azido precursor, prodrug and application | 中国科学院长春应用化学研究所 | 2025-05-16 | — | — | CN | claimed |
| CN-119185313-A | Leishmod prodrug, and preparation method and application thereof | 中国科学院长春应用化学研究所 | 2024-12-27 | — | — | CN | claimed |
| CN-118416861-A | Preparation method and application of magnetic graphene oxide-flavin molecularly imprinted material | 长江生态环保集团有限公司 | 2024-08-02 | — | — | CN | claimed |
| EP-0739208-A1 | FLAVIN DERIVATIVES AS ANTI-VIRAL AGENTS | RADOPATH LIMITED (GB) | 1996-10-30 | — | — | EP | claimed |
| WO-1995031194-A1 | COMPOSITIONS FOR TREATMENT OF CHRONIC INFLAMMATORY DISEASES | SHAPIRO HOWARD K (US) | 1995-11-23 | — | — | WO | claimed |
| WO-1995011028-A1 | FLAVIN DERIVATIVES AS ANTI-VIRAL AGENTS | RADOPATH LIMITED (GB) | 1995-04-27 | — | — | WO | claimed |
| EP-0384366-B1 | Photosensitive recording element | BASF AG (DE) | 1995-02-15 | — | — | EP | claimed |
| EP-0558280-A1 | Chemically amplified resist | JAPAN SYNTHETIC RUBBER CO., LTD. (JP) | 1993-09-01 | — | — | EP | claimed |
| WO-1993010784-A1 | THERAPEUTIC COMPOSITION AND METHOD FOR PREVENTING REPERFUSION INJURY | UNIVERSITY OF MICHIGAN (US) | 1993-06-10 | — | — | WO | claimed |
| EP-0523957-A1 | Radiation-sensitive composition | JAPAN SYNTHETIC RUBBER CO., LTD. (JP) | 1993-01-20 | — | — | EP | claimed |
| US-5153236-A | Comprising an N-aryl-alpha-amino acid and a photosensitizer such as a thixoanthone, isoalloxazine or coumarine; high sensitivity to UV and visible light; storage stability; photoresists; relief images | HITACHI CHEMICAL CO., LTD. (JP) | 1992-10-06 | — | — | US | claimed |
| US-5112723-A | Relief images, printing plates, photoresists, alloxazine compounds | BASF AKTIENGESELLSCHAFT (DE) | 1992-05-12 | — | — | US | claimed |
| US-4407821-A | LINOLENIC ACID OR ESTER, TRIGLYCERIDES | ROUSSEL UCLAF (FR) | 1983-10-04 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250188117-A1 | C-Terminal Peptide Modification | PTMS, NGLY1, QPCT | MEN1 276/4885KMT2A 3163/4885USP2 225/4885 |
| US-20260144875-A1 | COMPOSITIONS AND METHODS FOR CROSSLINKING STRUCTURAL PROTEINS | STRA6, RBP4, F12 | MEN1 4816/4885KMT2A 4211/4885USP2 908/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.